Form 4: CONMED Executive Receives 5,896 Restricted Stock Units

Johonna Marie Pelletier, CONMED Corp's Treasurer and VP, Tax, was granted 5,896 Restricted Stock Units under the company's 2025 Long-Term Incentive Plan.

Summary

• Johonna Marie Pelletier, Treasurer and VP, Tax of CONMED Corp (CNMD), was granted 5,896 Restricted Stock Units (RSUs).
• The grant date for these RSUs was March 2, 2026.
• Each RSU represents a contingent right to receive one share of CONMED common stock.
• The RSUs are subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan.
• Vesting will occur over a three-year period: 33% one year after the grant date, 33% in the second year, and 34% in the third year.
• The expiration date for these derivative securities is March 2, 2036.
• Following this transaction, Ms. Pelletier beneficially owns 5,896 derivative securities (RSUs).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, as it signifies continued executive alignment with shareholder interests through long-term equity incentives, which is a healthy corporate governance practice.

Positives

• The grant of Restricted Stock Units aligns the interests of a key executive, Johonna Marie Pelletier, with those of long-term shareholders.
• RSUs are a common form of equity compensation designed to incentivize executive retention and performance over a multi-year period.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic direction. It solely reports an executive's equity compensation grant.

Industry Context

StockSavvy.ai notes that the grant of Restricted Stock Units (RSUs) to a senior executive like a Treasurer and VP, Tax, is a standard practice in the medical technology and broader corporate sectors. This form of equity compensation is widely used to attract, retain, and motivate key personnel by linking their long-term financial interests directly to the company's stock performance, thereby encouraging sustained value creation.

Comparison to Industry Standards

• The RSU grant to Johonna Marie Pelletier is consistent with typical executive compensation structures observed across the medical device industry and other publicly traded companies.
• Similar RSU grants are common at peers like Stryker Corporation, Medtronic plc, and Zimmer Biomet Holdings, Inc., where equity awards form a significant component of executive pay to foster long-term alignment with shareholder value.
• The three-year vesting schedule is also a standard industry practice for such long-term incentive plans.

Stakeholder Impact

• Shareholders: The RSU grant aligns the executive's long-term financial interests with shareholder value creation, potentially leading to more focused management decisions aimed at increasing stock price.
• Employees: This type of compensation structure can serve as a model for other employees, demonstrating the company's commitment to performance-based incentives.

Next Steps

• The RSUs will vest over a three-year period, with tranches vesting on March 2, 2027, March 2, 2028, and March 2, 2029.
• Upon vesting, the RSUs will convert into shares of CONMED common stock.

Key Dates

Keywords

CONMED Corp, CNMD, Restricted Stock Units, RSU, Insider Transaction, Executive Compensation, Form 4, Equity Grant, Long-Term Incentive Plan